Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

Xarelto is available in four different strengths of tablets: 2.5 mg, 10 mg, 15 mg, and 20 mg. It also comes in pre-flavored oral suspension, which is 1 mg/milliliter (mL) strength. Prevention and ...

J&J has said it will now need upfront payment in full for its anticoagulant Xarelto (rivaroxaban) and immunology therapy Stelara (ustekinumab), with a rebate paid later, rather than the previous ...